Literature DB >> 1891353

Removal of psoralen monoadducts and crosslinks by human cell free extracts.

J T Reardon1, P Spielmann, J C Huang, S Sastry, A Sancar, J E Hearst.   

Abstract

Human cell free extracts are capable of carrying out damage-induced DNA synthesis in response to DNA damage by UV, psoralen, and cisplatin. We show that this damage-induced DNA synthesis is associated with removal of psoralen adducts and therefore is 'repair synthesis' and not an aberrant DNA synthesis reaction potentiated by DNA deformed by adducts. By comparing the denaturable fraction of psoralen adducted DNA which becomes labeled in the repair reaction to that of terminally labeled DNA (without repair) we have found that all DNA synthesis induced by psoralen monoadducts is the consequence of removal of these adducts. By the same approach we have obtained preliminary evidence that this in vitro system is capable of removing psoralen crosslinks as well.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1891353      PMCID: PMC328701          DOI: 10.1093/nar/19.17.4623

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

1.  Complementation of the xeroderma pigmentosum DNA repair defect in cell-free extracts.

Authors:  R D Wood; P Robins; T Lindahl
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

2.  Photochemistry of the furan-side 8-methoxypsoralen-thymidine monoadduct inside the DNA helix. Conversion to diadduct and to pyrone-side monoadduct.

Authors:  J W Tessman; S T Isaacs; J E Hearst
Journal:  Biochemistry       Date:  1985-03-26       Impact factor: 3.162

3.  Photochemical production of psoralen - DNA monoadducts capable of subsequent photocrosslinking.

Authors:  P K Chatterjee; C R Cantor
Journal:  Nucleic Acids Res       Date:  1978-10       Impact factor: 16.971

4.  RecA-dependent incision of psoralen-crosslinked DNA by (A)BC excinuclease.

Authors:  S Cheng; A Sancar; J E Hearst
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

5.  Substrate overlap and functional competition between human nucleotide excision repair and Escherichia coli photolyase and (a)BC excision nuclease.

Authors:  A Sancar
Journal:  Biochemistry       Date:  1990-06-19       Impact factor: 3.162

6.  Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication.

Authors:  W J Heiger-Bernays; J M Essigmann; S J Lippard
Journal:  Biochemistry       Date:  1990-09-11       Impact factor: 3.162

7.  Processing of psoralen adducts in an active human gene: repair and replication of DNA containing monoadducts and interstrand cross-links.

Authors:  J M Vos; P C Hanawalt
Journal:  Cell       Date:  1987-08-28       Impact factor: 41.582

8.  ATP-dependent partitioning of the DNA template into supercoiled domains by Escherichia coli UvrAB.

Authors:  H S Koo; L Claassen; L Grossman; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

9.  Psoralen-deoxyribonucleic acid photoreaction. Characterization of the monoaddition products from 8-methoxypsoralen and 4,5'8-trimethylpsoralen.

Authors:  D Kanne; K Straub; H Rapoport; J E Hearst
Journal:  Biochemistry       Date:  1982-03-02       Impact factor: 3.162

10.  Wavelength dependence for the photoreversal of a psoralen-DNA cross-link.

Authors:  G D Cimino; Y B Shi; J E Hearst
Journal:  Biochemistry       Date:  1986-05-20       Impact factor: 3.162

View more
  11 in total

1.  DNA interstrand cross-links induce futile repair synthesis in mammalian cell extracts.

Authors:  D Mu; T Bessho; L V Nechev; D J Chen; T M Harris; J E Hearst; A Sancar
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Repairing the Sickle Cell mutation. II. Effect of psoralen linker length on specificity of formation and yield of third strand-directed photoproducts with the mutant target sequence.

Authors:  Olga Amosova; Steven L Broitman; Jacques R Fresco
Journal:  Nucleic Acids Res       Date:  2003-08-15       Impact factor: 16.971

3.  Recombination induced by triple-helix-targeted DNA damage in mammalian cells.

Authors:  A F Faruqi; M M Seidman; D J Segal; D Carroll; P M Glazer
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

4.  Triple-helix formation induces recombination in mammalian cells via a nucleotide excision repair-dependent pathway.

Authors:  A F Faruqi; H J Datta; D Carroll; M M Seidman; P M Glazer
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

5.  Initiation of DNA interstrand cross-link repair in humans: the nucleotide excision repair system makes dual incisions 5' to the cross-linked base and removes a 22- to 28-nucleotide-long damage-free strand.

Authors:  T Bessho; D Mu; A Sancar
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

Review 6.  Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin.

Authors:  P Calsou; B Salles
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Human XPA and RPA DNA repair proteins participate in specific recognition of triplex-induced helical distortions.

Authors:  Karen M Vasquez; Jesper Christensen; Lei Li; Rick A Finch; Peter M Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

8.  Purification of PCNA as a nucleotide excision repair protein.

Authors:  A F Nichols; A Sancar
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

9.  Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts.

Authors:  P Calsou; P Frit; B Salles
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

10.  Human nucleotide excision nuclease removes thymine dimers from DNA by incising the 22nd phosphodiester bond 5' and the 6th phosphodiester bond 3' to the photodimer.

Authors:  J C Huang; D L Svoboda; J T Reardon; A Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.